首页> 外国专利> TrkB agonists Union, Nucleic Acid sequences which ENCODE, Expression Vectors comprising the recombinant host Cell, comprising such sequences.Method for the production of the agonist, Pharmaceutical composition containing the composition and its use for the manufacture of

TrkB agonists Union, Nucleic Acid sequences which ENCODE, Expression Vectors comprising the recombinant host Cell, comprising such sequences.Method for the production of the agonist, Pharmaceutical composition containing the composition and its use for the manufacture of

机译:TrkB激动剂联合,编码的核酸序列,包含重组宿主细胞的表达载体,包含此类序列。激动剂的制备方法,包含该组合物的药物组合物及其在制备中的用途

摘要

A Union of TrkB agonist, wherein Said Power agonism of TrkB agonist induced by BDNF and / or induced by NT - 4.The levels of TrkB agonist remains at the cell surface and can bind to an epitope within the film B and G, and the region between the sheets a and B ', the D5 domain of TrkB.One or more Nucleic Acid sequences which Encode the Union of TrkB agonist; one or more Expression Vectors comprising the Nucleic Acid sequences of one or more; a host Cell recombiThat includes one or more Nucleic Acid sequences or the one or more expression vector; and a method for the production of the Union of TrkB agonist which comprises cultivating the cell HueSpEd in conditions suitable for the expression of the Nucleic Acid Sequence or vector.A Pharmaceutical composition comprising the Union of TrkB agonist, and one or a combination of vehicles or pharmaceutically acceptable excipients, diluents.Use of Union of TrkB agonist for the manufacture of a Pharmaceutical composition for the treatment of a Neurological disorder or other disorder or the restoration or augmentation of the routeBDNF TrkB Activation of TrkB may be beneficial.Preferably, the Disorder is a neurodegenerative disease, Optic neuropathy, a degenerative disorder of the retina, a Disorder that involves hearing lossA Psychiatric Disorder, a Neurodevelopmental Disorder, a disorder of body weight Regulation, a Muscle disorder and other disorders of the CNS.More preferably, the Disorder is: Amyotrophic Lateral Sclerosis (ALS) and Huntington's Disease (HD), Alzheimer's Disease (AD), motor Neuron disease, Parkinson's disease,Prion disease, Lewy body disease, Spinal Muscular Atrophy, multiple Systems atrophy, Dementia and tauopathies, glaucoma, anterior ischemic Optic neuropathy (Aion)Posterior ischemic Optic neuropathy, neuropathy Optic Radiation Optic neuropathy, compressive Optic neuropathy mitochondrial Toxic Optic neuropathy, traumatic Optic Neuropathy.A Hereditary Optic neuropathy, Optic neuritis, age-related Macular Degeneration, retinitis pigmentosa, neural Deafness, Cochlear Deafness, sensorineural hearing loss, tinnitusHearing Loss composed, mood disorder, anxiety, depression, Panic Disorder, Post Traumatic Stress Disorder (PTSD), Attention deficit hyperactivity disorder (ADHD).Bipolar Disorder, Schizophrenia, Angelman Syndrome, Prader Willi Syndrome, autistic Disorder, Rett syndrome, anorexia, cachexia, unintended Weight Loss, obesity, Sarcopenia,Emesis induced by opioids, Sarcopenia, diabetic neuropathy, multiple sclerosis, Epilepsy, Migraine, nerve damage, Peripheral Neuropathy, Neuromuscular Disease, Sleep Disorder and Stroke.
机译:TrkB激动剂的联合,其中由BDNF诱导和/或NT-4诱导的TrkB激动剂的所述Power激动剂。TrkB激动剂的水平保留在细胞表面,并可以与膜B和G中的表位结合,并且一个或多个编码TrkB激动剂联合的核酸序列;在a和B'之间的区域,即TrkB的D5结构域。一种或多种表达载体,其包含一种或多种的核酸序列;宿主细胞重组,其包含一个或多个核酸序列或一个或多个表达载体;以及TrkB激动剂联盟的生产方法,其包括在适于表达核酸序列或载体的条件下培养细胞HueSpEd。药物组合物,其包含TrkB激动剂联盟和一种或多种媒介物或组合药学上可接受的赋形剂,稀释剂。TrkB激动剂联合会在制造用于治疗神经系统疾病或其他疾病或恢复或增强routeBDNF TrkB的药物组合物中的用途可能是有益的。神经退行性疾病,视神经病变,视网膜退行性疾病,涉及听力丧失的疾病精神病,神经发育疾病,体重调节疾病,肌肉疾病和中枢神经系统的其他疾病。 :肌萎缩性侧索硬化症(ALS)和亨廷顿舞蹈病(HD),阿尔茨海默氏病(AD),运动神经元病,帕金森氏病,普罗恩病,路易氏体病,脊髓性肌萎缩症,多系统萎缩症,痴呆症和眼球病,青光眼,前部缺血性视神经病(Aion),后部缺血性视神经病,神经病,视神经放射,视神经病,压迫性视神经病毒性视神经病变,外伤性视神经病变遗传性视神经病变,视神经炎,与年龄有关的黄斑变性,色素性视网膜炎,神经性耳聋,耳蜗性耳聋,感觉神经性听力损失,耳鸣组成的听力损失,情绪障碍,焦虑,抑郁,恐慌症,后期创伤性应激障碍(PTSD),注意力缺陷多动障碍(ADHD)。双相情感障碍,精神分裂症,安格曼综合症,普拉德威利综合症,自闭症,瑞特综合症,厌食症,恶病质,意外体重减轻,肥胖症,肌肉减少症,阿片类药物引起的呕吐,肌肉减少症,糖尿病性神经病,多发性硬化症,癫痫,偏头痛,神经水坝年龄,周围神经病变,神经肌肉疾病,睡眠障碍和中风。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号